AIH-2 affects around 10% of AIH patients, exhibits a more aggressive phenotype and has been related to the presence of HLA-DRB1*07 and DRB1*03 in cohorts in the UK and Brazil (74). This evidence concerns the gene HLA-DRB1 and autoimmune hepatitis.